Skip to main content
Clinical Trials/NCT01127932
NCT01127932
Completed
Not Applicable

Developing an Intervention to Address Suicide Risk During Substance Use Disorder

University of Michigan1 site in 1 country56 target enrollmentApril 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Suicide
Sponsor
University of Michigan
Enrollment
56
Locations
1
Primary Endpoint
Level of Suicidal Ideation
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This is a 2-year study designed to: (1) adapt and refine an existing cognitive-behavioral treatment (CBT) intervention to decrease suicidal thoughts and behaviors for use in Substance Use Disorder (SUD) treatment settings, and (2) conduct a pilot randomized controlled trial with 50 patients in treatment for SUDs comparing the CBT intervention to an enhanced control condition. Through this pilot randomized controlled trial, the investigators hope to not only obtain information about the feasibility of implementing these procedures in residential SUD treatment, but to also determine whether this intervention decreases the level of suicidal ideation, suicide attempts, hopelessness, and frequency of substance use relative to the control condition.

Detailed Description

Existing research indicates that problematic alcohol and drug use are closely linked to both fatal and non-fatal suicide attempts. Given the strong association between substance use and suicide, an episode of substance use disorder (SUD) treatment provides a unique opportunity to decrease the likelihood of suicidal behaviors. However, there are no data on the effectiveness of specific interventions designed to decrease suicidal thoughts and behaviors during an episode of SUD treatment in individuals at high risk for suicide. Patients for this trial will be screened at the SUD treatment site for a combination of a past suicide attempt and current suicidal ideation and will be randomized to CBT or control conditions. All participants in the pilot randomized controlled trial will be assessed at baseline, at the end of treatment, and at a 3-month follow-up. From a public health perspective, SUD treatment programs contain large numbers of patients at high risk for future suicidal behaviors and therefore have the potential to play a central role in our nation's efforts to decrease suicide.

Registry
clinicaltrials.gov
Start Date
April 2010
End Date
September 2011
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mark A. Ilgen

Associate Professor of Psychiatry

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Must be over 18 years of age
  • Report a past lifetime suicide attempt
  • Report current suicidal ideation
  • Resided in treatment for less than 4 weeks
  • In treatment for less than 6 months

Exclusion Criteria

  • Mental incompetence (e.g. unable to provide informed consent)
  • Diagnosis of schizophrenia or currently psychotic

Outcomes

Primary Outcomes

Level of Suicidal Ideation

Time Frame: Six months

Study Sites (1)

Loading locations...

Similar Trials